Mayne Pharma Group Balance Sheet Health
Financial Health criteria checks 5/6
Mayne Pharma Group has a total shareholder equity of A$454.2M and total debt of A$31.6M, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are A$1.1B and A$689.0M respectively.
Key information
7.0%
Debt to equity ratio
AU$31.64m
Debt
| Interest coverage ratio | n/a |
| Cash | AU$149.28m |
| Equity | AU$454.19m |
| Total liabilities | AU$688.99m |
| Total assets | AU$1.14b |
Recent financial health updates
Is Mayne Pharma Group (ASX:MYX) Using Too Much Debt?
Dec 01
Is Mayne Pharma Group (ASX:MYX) A Risky Investment?
Apr 12Mayne Pharma Group (ASX:MYX) Is Making Moderate Use Of Debt
Nov 10Mayne Pharma Group (ASX:MYX) Is Carrying A Fair Bit Of Debt
May 17Would Mayne Pharma Group (ASX:MYX) Be Better Off With Less Debt?
Dec 09
Recent updates
A Piece Of The Puzzle Missing From Mayne Pharma Group Limited's (ASX:MYX) 30% Share Price Climb
Sep 01Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade
Mar 06Analysts Just Slashed Their Mayne Pharma Group Limited (ASX:MYX) EPS Numbers
Dec 03Is Mayne Pharma Group (ASX:MYX) Using Too Much Debt?
Dec 01Is Mayne Pharma Group (ASX:MYX) A Risky Investment?
Apr 12Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade
Mar 01We Think Mayne Pharma Group Limited's (ASX:MYX) CEO Compensation Package Needs To Be Put Under A Microscope
Nov 16Mayne Pharma Group (ASX:MYX) Is Making Moderate Use Of Debt
Nov 10Mayne Pharma Group (ASX:MYX) Is Carrying A Fair Bit Of Debt
May 17Is Mayne Pharma Group Limited (ASX:MYX) Trading At A 37% Discount?
Mar 22How Many Mayne Pharma Group Limited (ASX:MYX) Shares Did Insiders Buy, In The Last Year?
Mar 01What You Need To Know About Mayne Pharma Group Limited's (ASX:MYX) Investor Composition
Feb 08Mayne Pharma Group Limited's (ASX:MYX) Shift From Loss To Profit
Jan 18Mayne Pharma Group's (ASX:MYX) Shareholders Are Down 75% On Their Shares
Dec 27Would Mayne Pharma Group (ASX:MYX) Be Better Off With Less Debt?
Dec 09A Quick Analysis On Mayne Pharma Group's (ASX:MYX) CEO Compensation
Nov 24Financial Position Analysis
Short Term Liabilities: MYX's short term assets (A$460.6M) exceed its short term liabilities (A$313.9M).
Long Term Liabilities: MYX's short term assets (A$460.6M) exceed its long term liabilities (A$375.1M).
Debt to Equity History and Analysis
Debt Level: MYX has more cash than its total debt.
Reducing Debt: MYX's debt to equity ratio has reduced from 36.5% to 7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MYX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MYX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 49.3% each year